Tarsus Pharmaceuticals, Inc. Stock Forecast
Red day on Wednesday for Tarsus Pharmaceuticals, Inc.
(Updated on Apr 24, 2024)
The Tarsus Pharmaceuticals, Inc. stock price fell by -2.82% on the last day (Wednesday, 24th Apr 2024) from $33.71 to $32.76. During the last trading day the stock fluctuated 5.99% from a day low at $32.41 to a day high of $34.35. The price has fallen in 8 of the last 10 days and is down by -8.7% for this period. Volume has increased on the last day by 96 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 308 thousand shares were bought and sold for approximately $10.09 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $32.36 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 18.08% during the next 3 months and, with a 90% probability hold a price between $38.20 and $51.39 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
TARS Signals & Forecast
There are few to no technical positive signals at the moment. The Tarsus Pharmaceuticals, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $33.34 and $33.94. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -16.47%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Tarsus Pharmaceuticals, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $30.61 and $30.50. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tarsus Pharmaceuticals, Inc. finds support just below today's level at $30.61. If this is broken, then the next support from accumulated volume will be at $30.50 and $27.98.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.94 between high and low, or 5.99%. For the last week, the stock has had daily average volatility of 5.56%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (TARS) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Tarsus Pharmaceuticals, Inc. to open at $33.17, and during the day (based on 14 day Average True Range), to move between $30.87 and $34.65, which gives a possible trading interval of +/-$1.89 (+/-5.78%) up or down from last closing price. If Tarsus Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 11.57% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $30.61 (6.56%) than the resistance at $36.35 (10.96%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Tarsus Pharmaceuticals, Inc. stock A Buy?
The Tarsus Pharmaceuticals, Inc. stock holds several negative signals and despite the positive trend, we believe Tarsus Pharmaceuticals, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -2.997 Sell Candidate Unchanged
Predicted Opening Price for Tarsus Pharmaceuticals, Inc. of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $33.17 ( 1.26%) | $32.76 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for TARS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 35.11 | 7.18 % | |
| R2 | 34.37 | 4.92 % | ||
| R1 | 33.91 | 3.52 % | ||
| Current price: | 32.76 | |||
| Support | S1 | 32.43 | -1.00 % | |
| S2 | 31.97 | -2.40 % | ||
| S3 | 31.23 | -4.66 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 39.22 | 19.72 % | |
| R2 | 36.95 | 12.79 % | ||
| R1 | 36.35 | 10.96 % | ||
| Current price | 32.76 | |||
| Support | S1 | 30.61 | -6.56% | |
| S2 | 30.50 | -6.90% | ||
| S3 | 27.98 | -14.59% |
FAQ
Click here for our free guide on how to buy Tarsus Pharmaceuticals, Inc. Stock.
